144 related articles for article (PubMed ID: 33709176)
1. Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma.
Goto M; Shibahara Y; Baciu C; Allison F; Yeung JC; Darling GE; Liu M
Ann Surg Oncol; 2021 Sep; 28(9):4943-4951. PubMed ID: 33709176
[TBL] [Abstract][Full Text] [Related]
2. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
5. CXCR7 expression in esophageal cancer.
Tachezy M; Zander H; Gebauer F; von Loga K; Pantel K; Izbicki JR; Bockhorn M
J Transl Med; 2013 Sep; 11():238. PubMed ID: 24074251
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
[TBL] [Abstract][Full Text] [Related]
7. CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.
D'Alterio C; Giardino A; Scognamiglio G; Butturini G; Portella L; Guardascione G; Frigerio I; Montella M; Gobbo S; Martignoni G; Napolitano V; De Vita F; Tatangelo F; Franco R; Scala S
Cells; 2022 Oct; 11(21):. PubMed ID: 36359736
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
9. CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
Schrevel M; Karim R; ter Haar NT; van der Burg SH; Trimbos JB; Fleuren GJ; Gorter A; Jordanova ES
Br J Cancer; 2012 Apr; 106(9):1520-5. PubMed ID: 22531719
[TBL] [Abstract][Full Text] [Related]
10. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
[TBL] [Abstract][Full Text] [Related]
11. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of CXCL12/CXCR4/CXCR7 axis in clear cell renal cell carcinoma.
Potić Floranović M; Ristić Petrović A; Veličković F; Janković Veličković L
Clin Exp Nephrol; 2021 Oct; 25(10):1057-1069. PubMed ID: 34109508
[TBL] [Abstract][Full Text] [Related]
13. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
[TBL] [Abstract][Full Text] [Related]
14. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
15. C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.
Guo J; Tong CY; Shi JG; Li XJ
Bioengineered; 2022 Mar; 13(3):7425-7438. PubMed ID: 35264069
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F; Tachezy M; Effenberger K; von Loga K; Zander H; Marx A; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Oncol; 2011 Aug; 104(2):140-5. PubMed ID: 21520098
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
18. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
19. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy.
Bargão Santos P; Lobo J; Félix A; Silva F; Manso RT; Costa JO; Lourenço B; Sequeira JP; Jerónimo C; Patel HHR; Henrique R
Urol Oncol; 2020 Oct; 38(10):794.e17-794.e27. PubMed ID: 32278731
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Desnoyer A; Dupin N; Assoumou L; Carlotti A; Gaudin F; Deback C; Peytavin G; Marcelin AG; Boué F; Balabanian K; Pourcher V;
Br J Dermatol; 2016 Dec; 175(6):1251-1262. PubMed ID: 27177037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
